Last month’s performance of -23.83% for Macrogenics Inc (MGNX) is certainly impressive

On Friday, Macrogenics Inc (NASDAQ: MGNX) opened lower -6.20% from the last session, before settling in for the closing price of $2.42. Price fluctuations for MGNX have ranged from $2.15 to $21.79 over the past 52 weeks.

A company in the Healthcare sector has jumped its sales by 18.02% annually for the last half of the decade. Company’s average yearly earnings per share was noted -636.67% at the time writing. With a float of $57.70 million, this company’s outstanding shares have now reached $62.76 million.

In an organization with 339 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 91.14%, operating margin of -75.78%, and the pretax margin is -69.07%.

Macrogenics Inc (MGNX) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Macrogenics Inc is 8.07%, while institutional ownership is 84.46%. The most recent insider transaction that took place on Feb 15 ’25, was worth 1,083. In this transaction VP, Controller & Treasurer of this company sold 423 shares at a rate of $2.56, taking the stock ownership to the 9,532 shares. Before that another transaction happened on Apr 04 ’24, when Company’s Senior VP and General Counsel sold 51,395 for $15.55, making the entire transaction worth $799,148. This insider now owns 0 shares in total.

Macrogenics Inc (MGNX) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -636.67% per share during the next fiscal year.

Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators

Check out the current performance indicators for Macrogenics Inc (MGNX). In the past quarter, the stock posted a quick ratio of 3.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.01.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.57, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -2.23 in one year’s time.

Technical Analysis of Macrogenics Inc (MGNX)

Let’s dig in a bit further. During the last 5-days, its volume was 0.56 million. That was inferior than the volume of 0.65 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 31.69%. Additionally, its Average True Range was 0.17.

During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 4.07%, which indicates a significant decrease from 15.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.75% in the past 14 days, which was higher than the 65.58% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.90, while its 200-day Moving Average is $3.65. However, in the short run, Macrogenics Inc’s stock first resistance to watch stands at $2.39. Second resistance stands at $2.51. The third major resistance level sits at $2.58. If the price goes on to break the first support level at $2.20, it is likely to go to the next support level at $2.13. The third support level lies at $2.01 if the price breaches the second support level.

Macrogenics Inc (NASDAQ: MGNX) Key Stats

There are currently 62,763K shares outstanding in the company with a market cap of 142.47 million. Presently, the company’s annual sales total 58,750 K according to its annual income of -9,060 K. Last quarter, the company’s sales amounted to 110,710 K and its income totaled 56,310 K.